SCHEMBL19863091

SCHEMBL19863091

c1ccc(-c2cc(-c3ccc(-c4cc5c6ccccc6oc5c5c4c4ccccc4n5-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.38
ALDH1A1 P00352 9/20 0.38
KMT2A Q03164 6/20 0.38
HPGD P15428 6/20 0.38
MEN1 O00255 5/20 0.38
NTSR1 P30989 1/20 0.35
KDM4E B2RXH2 7/20 0.34
LMNA P02545 5/20 0.34
GLA P06280 1/20 0.34
TSHR P16473 3/20 0.34
MAPK1 P28482 2/20 0.34
POLB P06746 2/20 0.34
HSD17B10 Q99714 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PDGFRB P09619 2/20 0.33
FLT3 P36888 2/20 0.33
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
GRM5 P41594 1/20 0.32
USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18594352 0.96 MAPT (0.37) MAPTALDH1A1KMT2AHPGDMEN1
SCHEMBL19863080 0.95 MAPT (0.36) MAPTALDH1A1KMT2AHPGDMEN1
SCHEMBL18594134 0.95 MAPT (0.36) MAPTALDH1A1KMT2AHPGDMEN1
SCHEMBL19863060 0.95 MAPT (0.36) MAPTALDH1A1KMT2AHPGDMEN1
SCHEMBL18594417 0.95 MAPT (0.38) MAPTALDH1A1KMT2AHPGDMEN1
SCHEMBL19863095 0.94 MAPT (0.36) MAPTALDH1A1KMT2AHPGDMEN1
SCHEMBL19863078 0.94 MAPT (0.35) MAPTALDH1A1KMT2AHPGDMEN1
SCHEMBL19863059 0.94 PDGFRB (0.34) MAPTALDH1A1KMT2AHPGDKDM4E
SCHEMBL19863092 0.92 MAPT (0.38) MAPTALDH1A1KMT2AHPGDMEN1
SCHEMBL18593780 0.91 MAPT (0.39) MAPTALDH1A1KMT2AHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 MAPT 746/4885ALDH1A1 242/4885KMT2A 177/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 MAPT 746/4885ALDH1A1 242/4885KMT2A 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.